Company Profile
biote Corp Stock Price, News & Analysis
- Ticker:
- BTMD
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, biote is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
2.15 USD (-4.44%)
Close
Last updated: June 23, 2026 at 00:00
65.21M USD
Market cap
Why the stock is moving
BTMD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
biote is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, biote is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
biote follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, biote sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer
Source: biote Corp
- 02
- 03
Biote Reports First Quarter 2026 Financial Results
Source: biote Corp
- 04
Biote Reports First Quarter 2025 Financial Results
Source: biote Corp
- 05
Biote Names Rich Barrera to Board of Directors
Source: biote Corp
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of biote Corp (BTMD)?
biote Corp (BTMD) most recently closed at 2.15 USD, a -4.44% move versus the previous session.
What is the market cap of biote Corp (BTMD)?
biote Corp currently has a market capitalization of 65.21M USD on BioPharmSignal.
What does biote Corp do?
biote is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is BTMD stock listed?
biote Corp (BTMD) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, biote is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Which conditions is biote Corp targeting with Investors?
biote is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.